2024 Rome, Italy
Meeting information
Abstracts
Programme Item
Presenter
Abstract Category
Search Abstract
I-39 Michael Heathman
A Categorical Time Course PKPD Model Describing the Effect of Ixekizumab on Improvement from Baseline in Psoriasis Area and Severity Index (PASI) score in Patients with Moderate to Severe Plaque Psoriasis
Wednesday 10:20-11:40